Can someone experience daily bleeding due to the Mirena (levonorgestrel) Intrauterine Device (IUD)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 6, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Yes, someone can experience daily bleeding with a Mirena IUD, and treatment options such as NSAIDs, hormonal treatment, or antifibrinolytic agents may be considered, depending on the patient's preferences, treatment goals, and medical history, as recommended by the 2024 U.S. Selected Practice Recommendations for Contraceptive Use 1.

The Mirena IUD, which releases levonorgestrel, a progestin hormone, can cause irregular spotting or breakthrough bleeding, especially during the first few months after insertion. According to the 2024 guidelines, for LNG-IUD users, such as Mirena, treatment options for spotting or light bleeding, or heavy/prolonged bleeding, may include NSAIDs, 5–7 days, hormonal treatment, 10–20 days, or antifibrinolytic agents, 5 days 1.

If daily bleeding persists, it is essential to explore patient goals, including continued method use or method discontinuation, and to consider underlying health conditions, such as interactions with other medications, sexually transmitted infections, pregnancy, thyroid disorders, or new pathologic uterine conditions, as recommended by the guidelines 1.

Key considerations for managing bleeding irregularities with Mirena IUD include:

  • Providing reassurance and advising the patient to contact their provider to discuss bleeding irregularities or other side effects
  • Offering treatment options, such as NSAIDs, hormonal treatment, or antifibrinolytic agents, depending on the patient's preferences and medical history
  • Considering underlying health conditions and treating or referring for care if necessary
  • Removing the IUD if the patient desires discontinuation, and offering counseling on alternative contraceptive methods 1.

From the Research

Daily Bleeding due to Mirena IUD

  • Daily bleeding can be a side effect of the Mirena IUD, especially during the initial months after insertion 2.
  • The Mirena IUD releases levonorgestrel, a progestin hormone that can cause changes in menstrual bleeding patterns, including irregular bleeding or spotting 3, 4.
  • Studies have shown that the Mirena IUD can reduce menstrual bleeding volume and frequency over time, but some women may experience persistent or increased bleeding 5, 4.
  • The effectiveness of the Mirena IUD in reducing bleeding varies depending on the individual and the underlying cause of the bleeding 5, 4.

Management of Bleeding associated with Mirena IUD

  • Non-steroidal anti-inflammatory drugs (NSAIDs) and tranexamic acid may be effective in reducing bleeding associated with IUD use 6, 5.
  • Vitamin B1 and mefenamic acid may also be effective in treating heavy menstrual bleeding associated with IUD use 5.
  • In some cases, the Mirena IUD may need to be removed or replaced if bleeding persists or is severe 3.

Quality of Life and Curative Effect

  • The Mirena IUD has been shown to improve quality of life and reduce symptoms of abnormal uterine bleeding in some women 4.
  • The curative effect of the Mirena IUD on abnormal uterine bleeding has been demonstrated in several studies, with significant reductions in bleeding volume and frequency 5, 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

[Ethical Aspects of the Use of Mirena(r) Iud in the Treatment of Heavy Menstrual Bleeding].

Cuadernos de bioetica : revista oficial de la Asociacion Espanola de Bioetica y Etica Medica, 2018

Research

Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause.

European journal of obstetrics, gynecology, and reproductive biology, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.